Average Co-Inventor Count = 1.56
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Esbatech, an Alcon Biomedical Research Unit LLC (6 from 36 patents)
2. Esbatech Ag (3 from 4 patents)
3. Other (1 from 832,891 patents)
4. Novartis Ag (1 from 3,923 patents)
5. Estabech, an Alcon Biomedical Research Unit LLC (1 from 1 patent)
6. Esbatech (1 from 1 patent)
7. Esbatech - a Novartis Company LLC (1 from 1 patent)
14 patents:
1. 10570190 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
2. 10125186 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
3. 9994645 - Acceptor framework for CDR grafting
4. 9518108 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
5. 9409979 - Acceptor framework for CDR grafting
6. 9403903 - Acceptor framework for CDR grafting
7. 9051366 - Acceptor framework for CDR grafting
8. 9005924 - Acceptor framework for CDR grafting
9. 8853362 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
10. 8399624 - Acceptor framework for CDR grafting
11. 8399625 - Acceptor framework for CDR grafting
12. 7258985 - Intrabodies with defined framework that is stable in a reducing environment and applications thereof
13. 7258986 - Intrabodies with defined framework that is stable in a reducing environment and applications thereof
14. 6821728 - Screening system